BEIJING, April 18, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTCBB:GTEC) announced that its Chinese pharmaceutical partner yesterday released its 2006 audited annual report. Lotus Pharmaceuticals, Inc. (OTCBB:LTUS) revealed gross revenues of $36 million, net profits of $4.1 million and net assets of $20.6 million.
Dr. Shaohua Tan, Genesis' Director headquartered in Beijing, also offered an update for the Genesis private-to-public program that operates under the name Genesis Equity Partners, LLC (GEP), a group of majority-owned subsidiaries, individually designated for each Chinese partner company. Among Dr. Tan's key comments were:
1. Lotus has shown good progress since becoming a GEP partner company
last March. GTEC owns 6.7 million LTUS common shares of the 50
million outstanding. Genesis maintains an active role in Lotus
operations and strategy, having appointed three members on its
board of directors, also serving in an ongoing consulting
capacity overseeing its U.S. office and activities.
2. Gold Horse International, Inc. (GHI) continues to advance to
public company status. Its official U.S. audit required an
updating through December 2006, which has now been completed by
Kabani & Company. GHI has moved into the late stages of the GEP
private-to-public program.
3. The other three GEP partner companies bear U.S. designations and
have entered the exacting U.S. auditing stage. China Environmental
Technologies, Oriental Health Beverages, and Sino Steel Structures
could produce significant profits and assets for Genesis, if
those Chinese companies' U.S. audits and legal due diligence
confirm internal reporting. With each company, Genesis would play
an active role in its management and strategy to attain its
goals and expansion.
4. The revised rules and regulations of the China Securities
Regulatory Commission (CSRC), invoked August-September 2006,
have placed a significant additional burden on GEP and its
competitors. While the full impact is still being determined,
it seems apparent that CSRC rulings have (a) increased the costs
and risks, (b) created additional steps with central government
involvement, and (c) delayed the process to complete the
private-to-public process. Dr. Tan closed by emphasizing that
"any future changes or revisions by the CSRC could have a major
impact on the GEP business model."
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that partners with qualified Chinese companies to expand their domestic and international market opportunities. The customized private-to-public program seeks to tap in to Western capital markets to attain this goal. Commitment, dedication, and expertise are the key components to the Genesis "Mission Statement." It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined "partner companies." Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.
Safe Harbor Statement and Disclaimer
Certain statements set forth in this press release constitute "forward-looking statements". Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission. The capital and growth program, the Company's central profit center, has specific risks and liabilities. Followers of our business model must understand that, until the Chinese partner company officially reaches public company status and files its initial Form 8-K, a high degree of risk exists that the partner may not ever attain that status. While receipt of a significant equity position in these companies is contractual, Genesis still recognizes that such compensation is conditional on performance and specific deliverables.